echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > The CRISPR system developed by GenKOre is recognized as a potential disruptor in the field of gene therapy

    The CRISPR system developed by GenKOre is recognized as a potential disruptor in the field of gene therapy

    • Last Update: 2021-11-03
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Daejeon, South Korea, October 20, 2021/PRNewswire/ - On September 2, 2021, GenKOre published a scientific paper in the online version (IF 54.


    gene scissor technology

    Only by delivering the genetic load to the necessary location in the patient can efficient gene therapy be performed, and the best way to achieve this is to use adeno-associated virus (AAV) as a vector


    The gene size of the "CRISPR/Cas12f-GE" system developed by GenKOre is 1/3 of that of Cas9, so it becomes the ideal load for AAV delivery


    The ultra-compact CRISPR system Cas12f-GE reveals its value as a therapeutic drug, and can be widely used to develop therapies for patients who suffer from lifelong diseases for a long time due to lack of fundamental therapies


    GenKOre, which successfully developed this new technology, is a spin-off company of Korea Research Institute of Bioscience & Biotechnology (KRIBB), a research institution funded by the Korean government


    GenKOre CEO Dr.


    With the successful development of CRISPR/Cas12f-GE, GenKOre plans to accelerate the development of gene therapy and new products through its unique gene scissors technology, and cooperate with other companies to strive to become a market leader in the field of gene therapy and new plant biotechnology


    To learn more about GenKOre's papers published on the online version of "Nature Biotechnology", please visit: https://


    Please visit GenKOre's website:.


    Source: GenKOre

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.